Skip to main content
OpenTrials
Completed

NCT Number: NCT00204945

Catheterization Laboratory Study: Acute Responses in Diastolic Heart Failure

1. Research question: What is the response of the heart's pumping function to changes in heart chamber pressures? 2. Experimental design: Patients undergoing routine cardiac catheterization will be studied. A thermodilution pulmonary artery catheter will be inserted through a venous sheath and threaded into the pulmonary artery. After several minutes of quiet rest, baseline hemodynamics will be obtained, including a determination of cardiac output using thermodilution techniques and 30 seconds of pressure recordings from the left ventricle and proximal aorta. In addition, a brief echocardiogram will be performed, to determine ejection fraction and indices of diastolic filling. Finally, arterial tonometry will be obtained in quick succession from the brachial, radial, femoral, and carotid arteries. Following the collection of baseline data, a bolus and infusion of nesiritide will be started. After 10 minutes of nesiritide infusion, with the drug still infusing, a full set of invasive hemodynamics will again be obtained, as well as brief echocardiographic and arterial tonometry examinations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Wisconsin Hospital and Clinics

Madison, Wisconsin, 53792, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cardiac catheterization

Exclusion criteria

  • Unstable coronary syndrome,
  • Critical coronary stenoses (>90%),
  • Severe peripheral vascular disease,
  • Symptomatic hypotension at completion of routine diagnostic cath,
  • Significant valvular disease, resting heart rate >120 beats/min,
  • Ejection fraction <45%,
  • Presence of contraindications to nesiritide administration,
  • Any evidence of clinical instability.

Treatment and study plan

Nesiritide

Drug

a bolus, then infusion of nesiritide for 10-15 minutes

Primary outcomes

  1. arterial tonometry

    Time frame: following catheterization, then following 10 minutes of nesiritide infusion

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • Scios, Inc.

Registry information

Official study title

Acute Responses in Diastolic Heart Failure

Important dates

Study start
2005
Primary completion
2007
Study completion
2007
First posted
Sep 20, 2005
Registry last updated
Feb 8, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.